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Abstract
Background: Recovery from substance use disorder (SUD) is often considered at odds with harm reduction strategies.
More recently, harm reduction has been categorized as both a pathway to recovery and a series of services to reduce
the harmful consequences of substance use. Peer recovery support services (PRSS) are effective in improving SUD
outcomes, as well as improving the engagement and effectiveness of harm reduction programs.
Methods: This study provides an initial evaluation of a hybrid recovery community organization providing PRSS as well
as peer-based harm reduction services via a syringe exchange program. Administrative data collected during normal
operations of the Missouri Network for Opiate Reform and Recovery were analyzed using Pearson chi-square tests and
Monte Carlo chi-square tests.
Results: Intravenous substance-using participants (N = 417) had an average of 2.14 engagements (SD = 2.59) with the
program. Over the evaluation period, a range of 5345–8995 sterile syringes were provided, with a range of 600–1530
used syringes collected. Participant housing status, criminal justice status, and previous health diagnosis were all
significantly related to whether they had multiple engagements.
Conclusions: Results suggest that recovery community organizations are well situated and staffed to also provide harm
reduction services, such as syringe exchange programs. Given the relationship between engagement and participant
housing, criminal justice status, and previous health diagnosis, recommendations for service delivery include additional
education and outreach for homeless, justice-involved, LatinX, and LGBTQ+ identifying individuals.
Keywords: Harm reduction, Syringe exchange, Peer recovery support services, Recovery community organizations,
Intravenous substance use

Background
Peer-based recovery community organizations (RCO)
and programs have presented unique opportunities for
the study of community responses to the opioid crisis in
the USA. In the last decade, the number of RCOs in the
USA has expanded in large part due to federal investment through the Recovery Community Services Program (RCSP) and Access to Recovery (ATR) Substance
Abuse and Mental Health Services Administration
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(SAMHSA) grants [1]. Outside of the USA, peer-based
harm reduction programs have shown that peer-delivered services are a viable option in reducing death and
transmission of disease and having a positive impact on
the quality of life of people who use drugs (PWUD) and
those seeking recovery [2–4]. As the USA continues to
expand its understanding and acceptance of harm reduction practices, RCOs can adapt to embrace both recovery and harm reduction strategies to play an even more
important role in communities impacted the most by
opioids and other substance use.
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Peer-based recovery community organizations

use. For example, a peer-based SEP in Vancouver increased the service reach of the SEP to individuals not
normally engaged by proto-typical programs [15]. More
recently, improved mental health outcomes have been
associated with the use of peer-based SEPs. For example,
Hay and colleagues reported that PWUD who engaged
with peer-based SEPs reported lower levels of depression
and anxiety and reported higher levels of life satisfaction,
compared to PWUD who engaged with non-peer-based
SEPs [16]. More importantly, the rate of health information exchange was greater for peer-based SEPs than
non-peer SEPs [16]. As RCOs have a robust peer workforce at the ready, the opportunity to bridge into
provision of harm reduction services may be possible.
For example, RCOs have a primary interest in the initiation of recovery and this is an area where harm reduction strategies have seen success. Previous evaluation of
SEPs has found that the successful referral of participants to SUD treatment is as high as 74% [18]. Additionally, of those referred, over 80% also remained engaged
in treatment for at least 90 days. Though SEPs were designed to decrease the risk of disease transmission—
which they are also successful with [19]—the programs
also engage participants in ancillary services at rates that
cannot be understated. With a plausible peer workforce
and a synergy in desired outcomes, it stands to reason
then that a hybrid model of RCO and peer-based SEP
(Fig. 1) may be an effective and innovative intervention.
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RCOs are non-profit, non-governmental organizations
which are directly led by members of recovery community (i.e., peers in recovery from substance use disorders)
[5]. The organizations provide recovery support services,
advocacy, and community education around substance
use disorder (SUD). RCOs are not only led by peers, but
peers also deliver the peer recovery support services
(PRSS) that are delivered programmatically; PRSS encompass peer recovery coaching, consumer advocacy,
mentoring, and facilitation of vocational groups focused
on employment, housing, and education [6]. RCOs have
emerged as a promising new innovation driven by social
need, created by the recovery community, and grown by
and for the populations they serve [7, 8]. From a service
standpoint, in addition to providing recovery-specific
brick and mortar space for pro-social activities and delivery of PRSS, RCOs also provide community outreach
and operate as an information and referral clearinghouse
for other SUD and non-SUD support organizations such
as local housing, local treatment providers, and other social support services [6].
PRSS are delivered in a variety of settings, including
RCOs [9], emergency departments [10], collegiate recovery programs [11], and in general community locations
[12]. In a recent systematic review, Bassuk and colleagues report that PRSS have a positive impact on participants and substance use disorder (SUD) outcomes
[13]. The study of PRSS remains in its infancy, and additional evaluation of the mechanism of action and
long-term effects is still needed. However, preliminary
evidence suggests that the use of peers in the recovery
process can lead to reductions in hospital readmissions
and length of sobriety, post-discharge treatment plan adherence, increased housing stability, and improvements
in mental health functioning [13].

Recovery community organizations providing harm
reduction services

The current study seeks to gain a better of the understanding of the characteristics of an RCO providing
peer-based SEP services (i.e., hybrid RCO model) through
a preliminary evaluation of the first known program in the
USA—the Missouri Safe Project (MO Safe) of the Missouri Network for Opiate Reform and Recovery (MO

Peer-based harm reduction strategies

Reflexively centered around recovery initiation and sustainment, a missing element in the framework of peer-delivered
recovery supports, especially in RCOs, is the capacity to accommodate and integrate harm reduction strategies. Harm
reduction initiatives—such as syringe exchange programs
(SEP) and drug consumption rooms—have shown reductions in the sharing of syringes [2], decreases in HIV infection rates [3], and reductions in overdose deaths [4]. While
many harm reduction initiatives are delivered in a traditional, professionalized manner, there are also
peer-delivered harm reduction strategies that mirror the
nature of PRSS [14–17].
Internationally, peers have been used to engage people
who use drugs (PWUDs) in an effort to connect to clinical services treatment and recovery supports, but also
to reduce the harms associated with active substance

Fig. 1 Peer SEP, RCO, and hybrid RCO comparison models. SEP =
syringe exchange program; RCO = recovery community organization
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Network). As of the writing of this paper, the MO Safe
project is the only RCO that officially provides an SEP
component.
We use a cross-sectional design to quantify the frequency of engagement (i.e., number of times served by
the program) and the descriptive characteristics of participants of this hybrid program—including HIV and
hepatitis C (HCV), housing, and criminal justice status.
The primary research hypothesis is that consumers will
engage multiple times with services delivered by the hybrid RCO, with those consumers who have HIV and
HCV engaging more frequently due to the added
provision of syringe exchange services. Additionally, by
determining the frequency of engagements and demographics of those served, it will be possible to better
identify and design engagement strategies to initiate recovery and reduce harm via future hybrid RCOs. Given
the infancy of the science involving RCOs and PRSS,
one scientific imperative is to lay the preliminary
groundwork for future study by surveying the first
known program to offer both peer-based recovery supports and harm reduction services. We believe that by
reporting the various taxonomy of RCO and harm reduction services, along with who utilizes such services
when delivered in concert, future study may be aimed at
establishing the ongoing efficacy of such organizations
and outcomes for those involved.
In summary, RCOs are continuing to expand throughout the country and peer support models are emerging
in various permutations from collegiate recovery programs to crisis point deployment such as in emergency
room settings for post-drug poisoning emergencies (i.e.,
overdose). It is clear that peer-based services and RCOs
will continue to grow as frontline recovery access and
sustainment mechanisms. The study of harm reduction
strategies as a component of RCO and peer-based services, such as SEPs, may open up a crucial area for the
expansion of the service mission of RCOs nationwide
and help design strategies for engagement of PWUD.

Methods
Missouri Network for Opiate Reform and Recovery:
Missouri Safe Project

The Missouri Network for Opiate Reform and Recovery
(MO Network) is an RCO established in 2015 that provides PRSS via a drop-in recovery center and mobile
outreach unit, recovery residences, naloxone distribution, and overdose education, as well as testing for HIV
and HCV. As part of the organization’s ongoing efforts
to respond to the opioid epidemic in Missouri, a partnership was formed with Criminal Justice Ministry in
2016 to begin offering syringe exchange services in a
comprehensive manner. Along with the services offered
through MO Network, the new project (Missouri Safe
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Project; MO Safe) began offering syringe exchange (with
no requirement to exchange used syringes in order to
receive sterile syringes, in accordance with international
best practice recommendations), wound care, sterile
supplies, and basic hygiene products. MO Network and
MO Safe services are provided by peers and both offered
at the drop-in center as well as via the mobile outreach
unit.
Recruitment

Recruitment was completed as part of regular operations
of the MO SAFE project; we analyzed administrative
data collected by project staff for the selected time
period and did not complete any data collection in
addition to the administrative data provided by project
staff. During February, March, and April 2018, participants were seen either at the MO Network recovery
drop-in center on a walk-in basis or via mobile outreach.
In each engagement, a peer specialist spoke with participants to discuss available services and resources as part
of MO Safe and the additional PRSS available via MO
Network. All data analyzed for this study were derived
from the participant’s file, which was comprised of data
collected and entered by the peer specialists from initial
and follow-up engagements. Participants provided consent that data derived from the engagement could be
used for future program evaluation. Following IRB review at Kennesaw State University, the study was indicated as exempt as it made use of de-identified data that
was collected for peer service delivery purposes.
Measures

Data from this study were identified and collected by
MO Network staff prior to the plans for this study. Participants provided basic demographic information (self-reported age, gender, race/ethnicity, sexual orientation),
as well as self-reported information related to housing
status, criminal justice involvement, HIV and HCV status, and any prior health diagnoses given to them by a
medical professional. Additionally, participants reported
whether naloxone had been administered to them between peer engagements and the number of sterile syringes received and used syringes returned; the number of
syringes exchanged is reported as a range due to the
manner in which data was collected by the program
staff. Program staff also recorded dates of peer engagement for each participant with a unique identifier code,
which we used to create a peer engagement variable. In
order to identify variables associated with participants
not returning after an initial engagement, participants
with only one unique engagement record were denoted
as “single engagement” and all participants with multiple
unique engagement records were denoted as “multiple
engagement.”
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Data analysis

All data was analyzed with SPSS V24.0. Descriptive statistics were analyzed for all participants. Following the
initial descriptive analysis, it was determined that ad hoc
testing of demographic and outcomes variables (e.g.,
Narcan administration, syringes received and returned,
single or multiple peer engagements) would be used to
identify any significant relationships. Initially, Pearson
chi-square tests were proposed; however, when analyzing
cross tabulations, it was determined that tables had
more than 20% of cells with a less than expected
5-count. Thus, Monte Carlo testing [20, 21] was used
when the cell count requirement was not satisfied. All
Monte Carlo tests were performed using 100,000 samples, random starting seed, and a 99% confidence interval (CI). Results from each Monte Carlo test are
reported using the chi-square likelihood ratio statistic,
degrees of freedom (DF), simulated exact p value, and
the 99% confidence interval (X2 (DF, N) = L.R statistic
value, p value, (99% CI LL, 99% CI UL).

Results
Participants

Participants (N = 417) had a mean age of 35.59 years
(SD = 10.42), with the majority being male (58.5%),
white/Caucasian (66.9%), and heterosexual (84.9%). All
participants (100%) were intravenous substance users.
More than half of participants reported stable housing
(55.9%). A large portion of participants reported having
HCV (34.1%), while a smaller percentage reporting having HIV (3.1%). Less than half of participants had either
previously been on, or were currently on, probation or
parole (38.1%). Only a small number of participants had

Fig. 2 Zip code heat map of intravenous substance use of participants
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co-occurring health concerns, with 13.4% reporting a
previous mental health illness. Participants reported
intravenous substance use in multiple zip codes surrounding St. Louis (Fig. 2); however, 41.9% of all reported use was in zip codes in, or adjacent to, the
physical location of MO Network’s drop-in center. Full
participant demographics are available in Table 1.
Naloxone administration, syringe exchange, and peer
engagement

All participants engaging in the MO Safe program are
current intravenous substance users. Overall, 895 total
peer engagements with 417 unduplicated participants
occurred during the study period (peer engagements: M
= 2.14, SD = 2.59). Slightly more than a third of all participants had multiple engagements (35.7%, N = 149). Of
the 895 total engagements, participants reported 151 instances (16.9%) of naloxone (e.g., brand name: Narcan)
administration since their last engagement. Additionally,
108 naloxone kits were given out to participants. Over
the course of the study period, the MO Safe program
dispensed a range of 5345–8995 sterile syringes, while a
range of 600–1530 used syringes were collected in the
same period. All participants (N = 417) received and
returned at least 1 sterile and 1 used syringe. Results
from all significant Monte Carlo chi-square tests are
available in Table 2.
Variance among participant health, housing, and criminal
justice variables

Monte Carlo chi-square tests were used to analyze relationships between various descriptive variables and outcomes variables.

(2018) 15:52
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Table 1 Participant characteristics

Table 1 Participant characteristics (Continued)
(n = 417)
n

(n = 417)
(%)

Age (years)
M = 35.59, SD = 10.42
Gender
Male

244

(58.5)

Female

166

(39.8)

Other

7

(1.7)

279

(66.9)

Race/ethnicity
White

n

(%)

Yes and 911 called

90

(6.8)

Yes and 911 not called

61

(10.1)

–

–

–

–

Narcan administered*

Sterile syringes dispensed
Range 5345–8955
Used syringes received
Range 600–1530

Black

99

(23.7)

Multi-racial

29

(7.0)

Other

10

(2.4)

Sexual orientation
Heterosexual

354

(84.9)

Bisexual

32

(7.7)

Homosexual

31

(7.5)

Housing status
Stable housing

233

(55.9)

Homeless

92

(22.1)

* n = 895 as result is calculated from all engagements with
duplicate participants

Multiple peer engagements and housing status

Results suggest that the relationship between having
multiple peer engagements and participant housing status was significant (X2 (4, N = 417) = 9.451, p = .050 (99%
CI, .049, .051). Participants reporting homelessness were
least likely to have multiple engagements compared to
clients reporting stable housing, transitional housing, or
living doubled up. Also, of note is that participants living
doubled up were most likely to have multiple engagements than any other reported housing status.

Transitional housing

11

(2.6)

Couch surfing

62

(14.9)

Multiple peer engagements and probation/parole status

Unknown

19

(4.6)

13

(3.1)

142

(34.1)

Results suggest that the relationship between having
multiple peer engagements and participant probation or
parole status was significant (X2 (3, N = 417) = 30.194, p
< .001 (99% CI, .000, .000). Participants who are currently on probation or parole were least likely to have
multiple engagements, while those who were not currently on probation/parole but had been previously were
most likely to have multiple engagements.

HIV status
Positive
HCV status
Positive
Probation/parole status
Currently on

36

(8.6)

Previously on

123

(29.5)

56

(13.4)

Medical diagnosis
Mental health diagnosis
Diabetes

7

(1.7)

Infection

13

(3.1)

Multiple

14

(3.4)

63111

71

(17.0)

63118

76

(18.2)

63116

28

(6.7)

Zip codes of highest use

Multiple engagements at RCO
Yes

149

(35.7)

Total number of participants (n = 417)
Total engagements = 895, M = 2.14, SD = 2.59
Total Narcan dispensed
IM

9

–

Nasal

99

–

Multiple peer engagements and previous health diagnosis

Results suggest that the relationship between having
multiple peer engagements and previous health diagnosis was significant (X2 (6, N = 417) = 32.485, p < .001
(99% CI, .000, .000). Participants that have had an infection, such as endocarditis, or have had previous mental
health diagnosis are least likely to have multiple engagements, while those with a previous diabetes diagnosis
are most likely to have multiple engagements.
Naloxone administration and probation/parole status

Results suggest that the relationship between naloxone
administration to the participant since the last peer engagement and participant probation or parole status was
significant (X2 (2, N = 417) = 22.693, p = .007 (99% CI,
.007, .008). Participants not currently on probation/parole but had been previously were least likely to have had
naloxone administered since the last peer engagement,
while participants currently on probation and parole
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Table 2 Significant Monte Carlo chi-square test results from multiple participant variable pairs
Variable pair

df

N

X2

p

99% CI (LL, UL)

Multiple peer engagements and housing status

4

417

9.451

.05

(.049, .051)

Multiple peer engagements and probation/parole status

3

417

30.194

< .001

(.000, .000)

Multiple peer engagements and previous health Dx

6

417

32.485

< .001

(.000, .000)

Multiple peer engagements and race/ethnicity

4

417

12.406

.011

(.010, .012)

Naloxone administration and probation/parole status

2

417

22.693

.007

(.007, .008)

Naloxone administration and sexual orientation

9

417

25.347

.018

(.017, .019)

Syringes received and HIV status

4

417

17.013

.024

(.022, .025)

Syringes returned and HIV status

6

417

14.042

.04

(.039, .042)

df degrees of freedom, CI confidence interval, LL lower limit, UL upper limit, Dx diagnosis

were most likely to have had naloxone administered
since the last peer engagement.
Syringes received and HIV status

Results suggest that the relationship between the number of syringes given to the participant and participant
HIV status was significant (X2 (4, N = 417) = 17.013, p
= .024 (99% CI, .022, .025). Participants who have positive HIV status were most likely to receive the highest
range of syringes (11–20 syringes) compared to those
who had a negative HIV status.
Syringes returned and HIV status

Results suggest that the relationship between the number of syringes returned by the participant and participant HIV status was significant (X2 (6, N = 417) = 14.042,
p = .040 (99% CI, .039, .042). Participants who have positive HIV status were most likely to return all ranges of
syringes (1–5, 6–11, 11–20 syringes) than participants
who have a negative HIV status.
Non-significant relationships

Results for the following variables were not significant
(p > .05) and suggest that there is no significant relationship between the variables: (a) multiple peer engagements and HIV or HCV status; (b) naloxone
administration and HIV or HCV status; (c) naloxone administration and housing status; (d) syringes received
and HCV status, housing status, probation/parole status,
or previous health diagnosis; and (e) syringes returned
and HCV status, housing status, probation/parole status,
or previous health diagnosis.
Variance among gender, race/ethnicity, and sexual
orientation variables

Monte Carlo chi-square tests were also used to analyze
relationships between various descriptive variables and
outcomes variables.

Multiple peer engagements and race/ethnicity

Results suggest that the relationship between having
multiple peer engagements and participant race/ethnicity was significant (X2 (4, N = 417) = 12.406, p = .011
(99% CI, .010, .012). Participants self-reporting as LatinX
(i.e., male and female Latin-identifying individuals;
LatinX is used as a gender-neutral term here) are least
likely to have multiple engagements, while participants
self-reporting as multiracial are most likely to have multiple engagements.
Naloxone administration and sexual orientation

Results suggest that the relationship between naloxone administration to the participant since the last peer engagement and participant sexual orientation was significant
(X2 (9, N = 417) = 25.347, p = .018 (99% CI, .017, .019).
Participants who identified as bisexual were most likely to
have naloxone administered since the last peer engagement, while homosexual clients were least likely to have
naloxone administered since the last peer engagement.
Non-significant relationships

Results for the following variables were not significant
(p > .05) and suggest that there is no significant relationship between the variables: (a) multiple peer engagements and gender or sexual orientation and (b)
naloxone administration and race or gender.

Discussion
Innovative, community-based programs are emerging
across the USA as a response to the opioid crisis. Many
of these programs are peer-based and provide a valuable
addition to the strained SUD treatment infrastructure in
the country [22]. Combining RCOs with harm-reduction
interventions, such as the MO Safe project, is one such
innovation that shows potential. RCOs have traditionally
provided PRSS and treatment referrals [23]. However,
recently, they have begun partnering with other entities
like primary health care and emergency departments to
provide initial engagement and referral for patients
experiencing an accidental drug poisoning (i.e., an
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overdose) [24]. Given the use of peers and RCO primary
goals of initiating and sustaining recovery, RCOs are well
positioned to expand their menu of services to include
harm reduction. Providing harm reduction services as a
supplement to recovery supports allows for engagement
of individuals who are at risk of disease, such as HCV
and HIV, and overdose. At-risk populations have been
found to engage at higher rates with peer-based initiatives [25, 26]. Additionally, for the subset of this at-risk
population that is interested in treatment initiation, the
close proximity to recovery supports and treatment referrals provides a distinct opportunity. The current study
provides preliminary evidence that a hybrid RCO/harm
reduction model is feasible and effective at engaging
people who inject drugs.
Previous research has reported that individuals who
struggle with homelessness are at high risk for overdose
[27]. Results from this study indicate that those without
stable housing were least likely to engage multiple times.
As a particularly vulnerable population, expanding outreach
from RCOs to homelessness encampments or mobile outreach teams could better engage individuals without stable
housing and at elevated risk for overdose.
Clients currently involved with the criminal justice system, especially those recently released from a criminal
justice facility, are also at higher risk for overdose [28, 29].
We found that participants currently on probation or parole were least likely to have multiple engagements and
were the most likely to have had naloxone administered
since their last engagement. RCOs have the capacity to engage individuals multiple times, and this should be a priority among individuals currently on probation and parole,
given the relationship to increased naloxone administration. Forming partnerships with local probation and parole professionals may increase engagement. It is possible
that the stigma and discrimination PWUD often experience via criminal justice professionals is related to the lack
of multiple engagements [30, 31] and should be further
explored and mediated given the elevated risk. Recent innovations highlighting partnerships between the criminal
justice system such as the Police Assisted Addiction and
Recovery Initiative (PAARI) [32, 33] could serve as models
for future partnerships.
Results from the current study indicate that individuals with previous infections are least likely to have multiple engagements with peer specialists. Increased
education regarding the potential benefits of continuing
to receive harm reduction services such as SEP or sterile
medical supplies may be warranted for this population.
HCV and HIV status were not significantly related to
having multiple engagements, suggesting that services
are perceived as beneficial to participants regardless of
HCV or HIV status. Participants that were positive for
HIV were most likely to receive a greater number of
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sterile syringes, as well as to return all ranges of used syringes. This finding is supportive of the continued use of
SEPs. Increasing the distribution of sterile syringes and
reclamation of used syringes is associated with a decline
in the transference of communicable disease, though
more research needs to be conducted, since multiple
confounding variables may impact the study of SEP efficacy [34]. However, the cost-benefit of such harm reduction strategies has been established [35].
The results highlight two other vulnerable populations
who may benefit from additional support. First, LatinX
participants were least likely to have multiple engagements. Relatable peers with culturally specific knowledge
should be used to increase culturally congruent services.
LatinX populations are at elevated risk for overdose and
HIV/HCV, and it is important to ensure continuous use
of services however possible. Second, bisexual participants were most likely to have had naloxone administered since the last engagement. Previous research has
reported similar findings [36], suggesting that bisexual
participants may benefit from additional overdose prevention education and assured naloxone distribution.
Limitations

Results from the current study should be viewed in light
of the following limitations. Given the transient and
often-criminalized status of the participants, self-report
measures may be inaccurate, under-reported, or misreported. Secondly, as the research team was not involved
in the data collection and management protocol, many
potentially beneficial variables and data points were not
collected. For example, the current evaluation did not
account for which PRSS were used by participants,
which brings into question the efficacy of offering recovery supports in addition to harm reduction services or if
utilization of other services minimizes the desire for
multiple peer specialist engagements. Data about syringes that were exchanged and distributed also suffers a
limiting factor in this way, as the program staff collected
this data via a wide range that only allowed for a wide
variance range in the results of the current study. Similarly, while it was reported that all participants were
intravenous substance users, the duration and severity of
all past substance use and all types of substances used
intravenously are unknown. Finally, though the sample
of the current study was large, it was isolated to one
small geographic area in the USA. As such, the results
are not generalizable to all populations.
Future directions

This study highlights the importance of data collection
and identifications for improved services in both RCO
operations and in harm reduction strategies. RCOs, especially those that provide harm reduction services,
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should seek to collect such data, identify areas of vulnerability, and adjust services to better respond to the needs
of vulnerable clients. While RCOs are still in their infancy, service delivery standards, identifying community
needs, and seeking more effective means of engaging clients should be a priority of such organizations. The
current study provides evidence that RCOs can successfully integrate harm reduction services with concurrent
PRSS offerings. The fusion of recovery supports and individual engagement through harm reduction may increase the chances that those with an ongoing SUD
remain connected to a community of recovery and that
such an organization can help safeguard health and wellbeing even with clients who may not be seeking recovery
at the time. RCOs and hybrid RCOs are a unique area
for future studies based in community- and
practice-based evidence with roots in action and participatory research.
More broadly, collaborative community inquiry and
action/participatory methodologies should be utilized in
future studies to establish practice-based evidence for research and service design [37–39]. Collaborative inquiry
and methodologies are fundamental to communitybased practice, research, and service delivery. The engagement of vulnerable populations should be formulated to simultaneously identify needs and build service
delivery methods through such inquiry [40, 41]. The use
of collaborative approaches can also help to address
potential limitations of data collection, such as experienced in the current study, as partnerships between
community-based organizations and research institutions can devise manners to cost-effectively and efficiently collect key data.
One strength of this study is in providing a roadmap
for ongoing identification of vulnerabilities in service delivery. Such analysis should be a contingency in the organizing and planning of services through community
assets such as RCOs. And finally, empirical assessment
of service impact should be closely aligned with subjective client experience and placed within a larger ecological theory as a general research framework. Future
research into RCOs, harm reduction strategies, and
community-based recovery support should seek to incorporate such mixed methods in order to best capture
community impact, user experience, and recovery phenomena in order to scientifically identify opportunities
to sustain life and stabilize health while helping to initiate and sustain SUD recovery.

Conclusion
RCOs are well-equipped to provide expanded services
bridging into the harm reduction arena. Peer-based services increase engagement of people with SUD or that
use substances regularly. RCOs that provide PRSS and
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harm reduction services should work to identify specific
populations at increased risk of overdose and disease
transmission and seek to address such populations with
targeted and tiered responses that begin with harm reduction strategies, education, and prevention while offering recovery services when applicable.
Evidence from this study suggests that syringe exchange programs (SEPs) embedded within RCOs provide
an additional method for reducing risk of infection, providing valuable resources, and increasing engagement
with vulnerable populations. The benefit of SEPs and the
cost-effectiveness of such programs are well established
and should be considered a fundamental best practice in
the harm reduction tool kit. Moving forward, it is also
worthwhile to begin considering adding these programs
as basic services in all RCOs.
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